AMY RIEDER: Open Payments
NPI 1679968002 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 99 payments from 19 companies in 2025. Trend: 2023 $1,638 · 2024 $1,873 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $389 |
| ABBVIE INC. | 17 | $247 |
| Lilly USA, LLC | 12 | $209 |
| Otsuka America Pharmaceutical, Inc. | 10 | $151 |
| Axsome Therapeutics, Inc. | 8 | $141 |
| Radius Health, Inc. | 3 | $126 |
| Novo Nordisk Inc | 6 | $104 |
| Astellas Pharma US Inc | 4 | $85 |
| Amgen Inc. | 4 | $60 |
| Exact Sciences Corporation | 3 | $50 |
Products named: AIRSUPRA, MOUNJARO, REXULTI, Auvelity, Tymlos, VRAYLAR, UBRELVY, FARXIGA.
Industry payments across KS — which companies pay providers there.
